Interpretation of Scientific Statement on Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods

VernacularTitle:《胎儿和新生儿时期心律失常药物治疗的科学声明》解读
Author: Yin WANG ^{1
,

2} ; Qinan YIN ; Lizhu HAN ; Yuan BIAN ; Pengwei WANG ; Jinqi LI
Author Information

1. 四川省医学科学院·四川省人民医院药学部,成都 610072
2. 电子科技大学医学院,个体化药物治疗四川省重点实验室,成都 610072
Keywords: Arrhythmia; Fetus; Neonate; Drug therapy
From: Herald of Medicine 2024;43(11):1723-1727
CountryChina
Language:Chinese
Abstract: On February 5,2024,the American Heart Association(AHA)released a scientific statement on the pharmacological management of cardiac arrhythmias in the fetal and neonatal periods.The statement discussed the mechanisms of arrhythmias,medication regimens,and fetal and neonatal aspects of pharmacokinetics.The statement proposed a consensus on drug treatment for arrhythmias in fetuses and newborns.This article interpreted the drug treatment part,and summarized the recommended medication and drug characteristics for fetal and neonatal arrhythmias to provide a reference for the drug treatment of fetal and neonatal arrhythmias in China.